
The UK’s House of Commons Science and Technology Committee has argued in a new report that the failure of clinical …

With shocking new findings revealing that around half of all clinical trial results in Europe go unreported, Matt Fellows explores …

A new study has revealed that African-American citizens make up a disproportionately high share of participants in US clinical trials …

A study published in the BMJ displayed the large degree of variation and lack of industry-standard when it comes to …

Sanofi has entered an ever-growing list of pharmaceutical companies that are pledging to limit the levels of their price increases …

Originally published in the October issue of Pharmafocus, Sean Murray takes a look at how pharma continues to occupy a key …

Amid the global political and economic turmoil taking place, one small pharma story got much less attention than it should …

Daiichi Sankyo has announced today that it will share clinical trial data to qualified researchers through an online web request …

GSK has put into practice its pledge to halt payments to doctors to promote its products at medical seminars – …

The majority of doctors, nurses, hospital specialists and pharmacists believe that payments received by healthcare professionals (HCPs) from pharmaceutical companies …

The pharma industry has excessive power over EU decision-makers and spends €40 million a year to influence EU drug policy, …

Even in an industry as litigious as pharma can sometimes be, the recent legal drama that has played out in …
During the time I worked as research, medical and innovation director at the ABPI, between October 2012 and January 2015, …

Healthcare professionals who have inappropriate financial links with pharma companies will face prosecution and up to 10 years in jail, …
The Ethical Medicines Industry Group and Sense About Science – a co-founder of the ALLTrials campaign – have written a …